A detailed history of Private Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Private Asset Management Inc holds 1,361 shares of AMGN stock, worth $429,449. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,361
Previous 2,048 33.54%
Holding current value
$429,449
Previous $454,000 19.6%
% of portfolio
0.09%
Previous 0.09%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

SELL
$218.65 - $271.46 $150,212 - $186,493
-687 Reduced 33.54%
1,361 $365,000
Q2 2023

Jul 05, 2023

SELL
$214.27 - $253.37 $55,710 - $65,876
-260 Reduced 11.27%
2,048 $454,000
Q1 2023

Apr 04, 2023

SELL
$225.79 - $275.2 $23,030 - $28,070
-102 Reduced 4.23%
2,308 $557,000
Q4 2022

Jan 04, 2023

SELL
$229.03 - $291.01 $7,787 - $9,894
-34 Reduced 1.39%
2,410 $633,000
Q2 2022

Jul 06, 2022

SELL
$230.71 - $256.74 $23,071 - $25,674
-100 Reduced 3.93%
2,444 $595,000
Q1 2022

Apr 04, 2022

BUY
$219.27 - $242.57 $180,897 - $200,120
825 Added 47.99%
2,544 $615,000
Q4 2021

Jan 03, 2022

SELL
$198.88 - $227.6 $19,888 - $22,760
-100 Reduced 5.5%
1,719 $387,000
Q3 2021

Oct 04, 2021

SELL
$212.27 - $248.7 $32,689 - $38,299
-154 Reduced 7.81%
1,819 $387,000
Q2 2021

Jul 06, 2021

SELL
$233.58 - $259.14 $61,431 - $68,153
-263 Reduced 11.76%
1,973 $481,000
Q1 2021

Apr 02, 2021

BUY
$221.91 - $258.6 $14,867 - $17,326
67 Added 3.09%
2,236 $556,000
Q4 2020

Jan 05, 2021

SELL
$216.38 - $257.67 $83,522 - $99,460
-386 Reduced 15.11%
2,169 $499,000
Q3 2020

Oct 06, 2020

SELL
$234.65 - $260.95 $7,743 - $8,611
-33 Reduced 1.28%
2,555 $649,000
Q1 2020

Apr 02, 2020

SELL
$182.24 - $241.7 $21,139 - $28,037
-116 Reduced 4.29%
2,588 $525,000
Q3 2019

Oct 02, 2019

SELL
$174.11 - $208.62 $115,783 - $138,732
-665 Reduced 20.34%
2,604 $480,000
Q3 2019

Oct 02, 2019

BUY
$174.11 - $208.62 $17,411 - $20,862
100 Added 3.84%
2,704 $523,000
Q1 2019

Apr 03, 2019

BUY
$180.87 - $203.88 $60,048 - $67,688
332 Added 11.3%
3,269 $621,000
Q4 2018

Jan 08, 2019

SELL
$178.4 - $208.25 $137,724 - $160,769
-772 Reduced 20.81%
2,937 $572,000
Q3 2018

Oct 02, 2018

SELL
$185.29 - $208.89 $8,338 - $9,400
-45 Reduced 1.2%
3,709 $769,000
Q2 2018

Jul 23, 2018

SELL
$166.05 - $186.51 $66,586 - $74,790
-401 Reduced 9.65%
3,754 $693,000
Q2 2018

Jul 10, 2018

BUY
$166.05 - $186.51 $66,420 - $74,604
400 Added 10.65%
4,155 $708,000
Q1 2018

Apr 06, 2018

SELL
$169.43 - $198.0 $8,471 - $9,900
-50 Reduced 1.31%
3,755 $640,000
Q4 2017

Jan 05, 2018

SELL
$168.79 - $188.59 $59,076 - $66,006
-350 Reduced 8.42%
3,805 $662,000
Q3 2017

Oct 04, 2017

BUY
$167.29 - $191.0 $565,440 - $645,580
3,380 Added 436.13%
4,155 $775,000
Q3 2017

Oct 03, 2017

BUY
$167.29 - $191.0 $129,649 - $148,025
775
775 $775 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Private Asset Management Inc Portfolio

Follow Private Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Private Asset Management Inc with notifications on news.